You have 9 free searches left this month | for more free features.

adult acute lymphoblastic leukemia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)

Recruiting
  • Acute Lymphoid Leukemia
  • +3 more
  • São Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
Jul 24, 2023

Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia Trial

Completed
  • Acute Undifferentiated Leukemia
  • +13 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Apr 5, 2022

B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • HY004
  • +2 more
  • (no location specified)
Aug 18, 2023

Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital of Sun Yat-sen University
Sep 25, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Chicago, Illinois
  • +2 more
Jan 12, 2023

Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +14 more
  • radiation therapy
  • +8 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Oct 7, 2022

Determining the Mechanisms of Loss of CAR T Cell Persistence

Not yet recruiting
  • Acute Lymphoblastic Leukemia With Failed Remission
  • +4 more
    • (no location specified)
    Mar 29, 2023

    Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)

    Recruiting
    • Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Dec 13, 2022

    B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

    Not yet recruiting
    • B Acute Lymphoblastic Leukemia
    • +2 more
    • Azacitidine Injection
    • +2 more
    • (no location specified)
    Oct 15, 2023

    Acute Lymphoblastic Leukemia, Adult, Invasive Fungal Infections Trial in Rome (observation of invasive fungal infections)

    Recruiting
    • Acute Lymphoblastic Leukemia, Adult
    • Invasive Fungal Infections
    • observation of invasive fungal infections
    • Rome, Italy
      Fondazione Policlinico Universitario A. Gemelli IRCCS
    Feb 20, 2023

    Clinical Significance of Occult Central Nervous System

    Recruiting
    • Acute Lymphoblastic Leukemia
    • cerebrospinal fluids exams
    • Roma, RM, Italy
      Tor Vergata University
    Mar 17, 2023

    Acute Lymphoblastic Leukemia Trial in New York (Venetoclax)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 2, 2023

    T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)

    Terminated
    • T-Acute Lymphoblastic Leukemia
    • Adult T Lymphoblastic Lymphoma
    • Saint Louis, Missouri
    • +1 more
    Jan 18, 2023

    Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

    Suspended
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Nov 28, 2022

    Acute Lymphoblastic Leukemia Trial (inotuzumab ozogamicin)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • inotuzumab ozogamicin
    • (no location specified)
    Jan 6, 2023

    Patients Who Received Inotuzumab Ozogamicin for B-cell ALL That

    Not yet recruiting
    • Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
    • Inotuzumab Ozogamicin
    • (no location specified)
    Nov 3, 2022

    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

    Recruiting
    • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
    • +9 more
    • Duarte, California
      City of Hope Medical Center
    May 19, 2022

    Postural Control Under Different Cognitive Loads in Adult

    Completed
    • Acute Lymphoblastic Leukemia
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Sep 16, 2022

      Acute Lymphoblastic Leukemia Trial in Tianjin (CN201)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Oct 14, 2022

      Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma Trial in United States (DNR, VCR, PEG-asp)

      Terminated
      • Acute Lymphocytic Leukemia
      • Adult Lymphoblastic Lymphoma
      • La Jolla, California
      • +3 more
      Apr 26, 2022

      Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage I Adult

      Completed
      • Contiguous Stage II Adult Lymphoblastic Lymphoma
      • +5 more
      • Sacramento, California
        University of California Davis
      Mar 8, 2022

      DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid

      Completed
      • Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
      • +8 more
      • Laboratory Biomarker Analysis
      • Philadelphia, Pennsylvania
        Childrens Oncology Group
      Jul 12, 2022

      Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory Trial in Memphis (drug, device, biological)

      Active, not recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • Acute Lymphoblastic Leukemia, Refractory
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Jan 3, 2023

      CAR, Refractory Acute Lymphoblastic Leukemia, Relapsed Adult ALL Trial in Suzhou (Treatment)

      Recruiting
      • CAR
      • +2 more
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Dec 27, 2022